Page last updated: 2024-10-28

gyki 52466 and Benign Infantile Myoclonic Epilepsy

gyki 52466 has been researched along with Benign Infantile Myoclonic Epilepsy in 2 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Two potent glutamate antagonists, NBQX and GYKI 52466, that act selectively on non-NMDA receptors, have been tested for anticonvulsant activity in 3 models of reflex epilepsy (sound-induced seizures in DBA/2 mice and in genetically epilepsy-prone rats and photically-induced myoclonus in Papio papio) and in amygdala kindled rats."3.68The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates. ( Chapman, AG; Craggs, MD; Dürmüller, N; Meldrum, BS; Smith, SE, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meldrum, BS2
Craggs, MD1
Dürmüller, N2
Smith, SE2
Chapman, AG1

Other Studies

2 other studies available for gyki 52466 and Benign Infantile Myoclonic Epilepsy

ArticleYear
The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates.
    Epilepsy research. Supplement, 1992, Volume: 9

    Topics: Acoustic Stimulation; Amygdala; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Cere

1992
The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy.
    European journal of pharmacology, 1991, Aug-29, Volume: 201, Issue:2-3

    Topics: Acoustic Stimulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Benzodiazepin

1991